Ran Nussbaum
Director, Kite Pharma.
Companies
- LB PHARMACEUTICALS INCBoard member Sep 11, 2025 to now1
- Keros Therapeutics, Inc.Board member Apr 7, 2020 to now2
- UroGen Pharma Ltd.Board member Jan 10, 2019 to Feb 28, 20233
- Eloxx Pharmaceuticals, Inc.Board member Dec 29, 2017 to Jun 17, 20224
- VBI Vaccines Inc/BCBoard member Oct 31, 2017 to Oct 31, 20175
- Kite PharmaBoard member Jun 19, 2014 to Oct 5, 20176
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- UroGen Pharma Ltd. URGN1,485,168 shares7$54.0M at $36.36Oct 21, 2022
- LB PHARMACEUTICALS INC LBRX1,411,681 shares8$51.8M at $36.69Sep 12, 2025
- Keros Therapeutics, Inc. KROS160,512 shares9$1.8M at $11.10Jun 11, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 12, 2025Bought 1,000,000 shares at $15.00 of LB PHARMACEUTICALS INC8
- Sep 12, 2025Converted 411,681 shares of LB PHARMACEUTICALS INC8
- Jun 4, 2025Granted 5,250 shares of Keros Therapeutics, Inc.10
- Nov 29, 2022Exercised 1,914 shares of Keros Therapeutics, Inc.11
- Nov 29, 2022Exercised 1,723 shares of Keros Therapeutics, Inc.11
- Nov 29, 2022Exercised 3,539 shares of Keros Therapeutics, Inc.11
- Oct 21, 2022Exercised options 47,999 shares at $5.94 of UroGen Pharma Ltd.12
- Oct 21, 2022Exercised options 47,999 shares at $5.94 of UroGen Pharma Ltd.7
- Jun 16, 2022Exercised options 2,211 shares at $5.00 of UroGen Pharma Ltd.13
- Jun 6, 2022Exercised options 1,030 shares at $5.00 of UroGen Pharma Ltd.14
- Jun 6, 2022Exercised options 1,030 shares at $5.00 of UroGen Pharma Ltd.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLB PHARMACEUTICALS INC, Board member
- 2
- 3SEC EDGARUroGen Pharma Ltd., Board member
- 4
- 5SEC EDGARVBI Vaccines Inc/BC, Board member
- 6SEC EDGARKite Pharma, Board member
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 6, 2025
- 11SEC EDGARForm 4 filed Nov 30, 2022
- 12SEC EDGARForm 4 filed Oct 25, 2022
- 13SEC EDGARForm 4 filed Feb 28, 2023
- 14SEC EDGARForm 4 filed Aug 25, 2022
- 15SEC EDGARForm 4 filed Feb 28, 2023